Center-Authored Papers

Filters: Author is Lange, Paul H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Larson SR, Zhang X, Dumpit R, Coleman I, Lakely B, Roudier M, Higano CS, True LD, Lange PH, Montgomery B et al..  2013.  Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.. The Prostate. 73(9):932-40. Abstract
Roudier MP, Winters BR, Coleman I, Lam H-M, Zhang X, Coleman R, Chéry L, True LD, Higano CS, Montgomery B et al..  2016.  Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.. The Prostate. 76(9):810-22. Abstract
D
Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Nelson PS, Coleman R, Wang Y-C, Corey E, Lange PH et al..  2008.  Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.. Clinical & experimental metastasis. 25(4):377-88. Abstract
E
Haider M, Zhang X, Coleman I, Ericson N, True LD, Lam H-M, Brown LG, Ketchanji M, Nghiem B, Lakely B et al..  2015.  Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.. Clinical & experimental metastasis. Abstract
Kumar A, White TA, MacKenzie AP, Clegg N, Lee C, Dumpit RF, Coleman I, Ng SB, Salipante SJ, Rieder MJ et al..  2011.  Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.. Proceedings of the National Academy of Sciences of the United States of America. 108(41):17087-92. Abstract
G
Holcomb IN, Grove DI, Kinnunen M, Friedman CL, Gallaher IS, Morgan TM, Sather CL, Delrow JJ, Nelson PS, Lange PH et al..  2008.  Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients.. Cancer research. 68(14):5599-608. Abstract
H
Wu Y, Schoenborn JR, Morrissey C, Xia J, Larson S, Brown LG, Qu X, Lange PH, Nelson PS, Vessella RL et al..  2015.  High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer.. The Journal of molecular diagnostics : JMD. Abstract
L
Nguyen HM, Vessella RL, Morrissey C, Brown LG, Coleman IM, Higano CS, Mostaghel EA, Zhang X, True LD, Lam H-M et al..  2017.  LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.. The Prostate. Abstract
N
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL et al..  2009.  NCCN clinical practice guidelines in oncology: kidney cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(6):618-30.
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL et al..  2009.  NCCN clinical practice guidelines in oncology: testicular cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(6):672-93.
Carroll PR, Parsons KJ, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB et al..  2016.  NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(5):509-19. Abstract
P
Wright JL, Dalkin BL, True LD, Ellis WJ, Stanford JL, Lange PH, Lin DW.  2010.  Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.. The Journal of urology. 183(6):2213-8. Abstract
Carroll PR, Parsons KJ, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI et al..  2015.  Prostate Cancer Early Detection, Version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(12):1534-61. Abstract
Izard JP, True LD, May P, Ellis WJ, Lange PH, Dalkin B, Lin DW, Schmidt RA, Wright JL.  2014.  Prostate Cancer That Is Within 0.1 mm of the Surgical Margin of a Radical Prostatectomy Predicts Greater Likelihood of Recurrence.. The American journal of surgical pathology. 38(3):333-8. Abstract
Qian DZ, Huang C-Y, O'Brien CA, Coleman IM, Garzotto M, True LD, Higano CS, Vessella R, Lange PH, Nelson PS et al..  2009.  Prostate cancer-associated gene expression alterations determined from needle biopsies.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(9):3135-42. Abstract
S
Gulati R, Cheng HH, Lange PH, Nelson PS, Etzioni R.  2016.  Screening men at increased risk for prostate cancer diagnosis: Model estimates of benefits and harms.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Welty CJ, Coleman I, Coleman R, Lakely B, Xia J, Chen S, Gulati R, Larson SR, Lange PH, Montgomery B et al..  2013.  Single cell transcriptomic analysis of prostate cancer cells.. BMC molecular biology. 14:6. Abstract
Zhang X, Coleman I, Brown LG, True LD, Kollath L, Lucas JM, Lam H-M, Dumpit R, Corey E, Chéry L et al..  2015.  SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Kumar A, Coleman I, Morrissey C, Zhang X, True LD, Gulati R, Etzioni R, Bolouri H, Montgomery B, White T et al..  2016.  Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.. Nature medicine. Abstract
T
Sim HG, Telesca D, Culp SH, Ellis WJ, Lange PH, True LD, Lin DW.  2008.  Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.. The Journal of urology. 179(5):1775-9. Abstract
W
Lin B, Utleg AG, Gravdal K, White JT, Halvorsen OJ, Lu W, True LD, Vessella R, Lange PH, Nelson PS et al..  2008.  WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(5):1397-406. Abstract